Retaglutide is a novel GLP-1 receptor agonist currently under study for the control of metabolic disorders. This therapy works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone https://harmonyzdaa813531.blogocial.com/semaglutide-a-potential-solution-for-obesity-74868808